• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从主观认知下降到轻度认知障碍的进展风险:研究环境的作用。

Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting.

机构信息

Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Alzheimers Dement. 2018 Jun;14(6):734-742. doi: 10.1016/j.jalz.2017.12.003. Epub 2018 Jan 18.

DOI:10.1016/j.jalz.2017.12.003
PMID:29352855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5994356/
Abstract

INTRODUCTION

We compared risk of progression from subjective cognitive decline (SCD) to mild cognitive impairment (MCI) in an academic memory clinic versus a population-based study.

METHODS

Older adults presenting at a memory clinic were classified as SCD (n = 113) or as noncomplainers (n = 82). Participants from a population study were classified as SCD (n = 592) and noncomplainers (n = 589) based on a memory complaint score. Annual follow-up performed for a mean of 3 years.

RESULTS

The adjusted hazard ratio for SCD was 15.97 (95% confidence interval: 6.08-42.02, P < .001) in the memory clinic versus 1.18 (95% confidence interval: 1.00-1.40, P = .047) in the population study, where reported "worry" about memory further increased SCD-associated risk for MCI.

DISCUSSION

SCD is more likely to progress to MCI in a memory clinic than the general population; participants' characteristics vary across settings. Study setting should be considered when evaluating SCD as a risk state for MCI and dementia.

摘要

简介

我们比较了在学术记忆诊所和基于人群的研究中,从主观认知下降(SCD)进展为轻度认知障碍(MCI)的风险。

方法

在记忆诊所就诊的老年人被分为 SCD(n=113)或非抱怨者(n=82)。基于记忆抱怨评分,人群研究中的参与者被分为 SCD(n=592)和非抱怨者(n=589)。平均随访 3 年。

结果

与人群研究中的 1.18(95%置信区间:1.00-1.40,P=0.047)相比,记忆诊所中的 SCD 的调整后危险比为 15.97(95%置信区间:6.08-42.02,P<0.001),报告“担心”记忆进一步增加了与 MCI 相关的 SCD 风险。

讨论

与一般人群相比,SCD 在记忆诊所更有可能进展为 MCI;参与者的特征在不同环境中有所不同。在评估 SCD 作为 MCI 和痴呆的风险状态时,应考虑研究环境。

相似文献

1
Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting.从主观认知下降到轻度认知障碍的进展风险:研究环境的作用。
Alzheimers Dement. 2018 Jun;14(6):734-742. doi: 10.1016/j.jalz.2017.12.003. Epub 2018 Jan 18.
2
Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.主观认知下降和轻度认知障碍患者的脑脊液生物标志物与临床进展
J Alzheimers Dis. 2017;58(3):939-950. doi: 10.3233/JAD-161252.
3
Associations between Informant-Reported Cognitive Complaint and Longitudinal Cognitive Decline in Subjective Cognitive Decline A 7-Year Longitudinal Study.主观认知衰退中信息提供者报告的认知主诉与纵向认知衰退之间的关联:一项7年纵向研究
Arch Clin Neuropsychol. 2024 May 21;39(4):409-417. doi: 10.1093/arclin/acad096.
4
The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline.用于排除轻度认知障碍的标准会影响主观认知下降患者的痴呆发病率。
Alzheimers Res Ther. 2024 Jun 28;16(1):142. doi: 10.1186/s13195-024-01516-6.
5
Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.帕金森病患者的主观认知衰退与向痴呆的进展:一项长期随访研究。
J Neurol. 2019 Mar;266(3):745-754. doi: 10.1007/s00415-019-09197-0. Epub 2019 Jan 11.
6
Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies.主观认知衰退:未来痴呆和轻度认知障碍的风险水平,一项纵向研究的荟萃分析。
Neuropsychol Rev. 2022 Dec;32(4):703-735. doi: 10.1007/s11065-021-09522-3. Epub 2021 Nov 8.
7
Subjective Cognitive Decline as a predictor of Frailty in older adults: Hellenic Longitudinal Investigation of Aging and Diet study (HELIAD).主观认知衰退是老年人衰弱的预测指标:希腊老龄化和饮食研究的纵向研究 (HELIAD)。
J Frailty Aging. 2023;12(3):198-207. doi: 10.14283/jfa.2023.28.
8
Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.从社区和记忆诊所招募的 SCD 患者的横断面和纵向特征:主观认知下降、心理情感因素、认知表现以及随时间的进展的萎缩。
Alzheimers Res Ther. 2019 Jul 8;11(1):61. doi: 10.1186/s13195-019-0514-z.
9
Memory complaint in a middle-income country: a four-year longitudinal study in a cohort with low-education.中低收入国家的记忆主诉:一项低教育队列的四年纵向研究。
Arq Neuropsiquiatr. 2024 May;82(5):1-9. doi: 10.1055/s-0044-1787138. Epub 2024 Jun 7.
10
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.从主观认知衰退到阿尔茨海默病:神经心理学评估、人格特质和认知储备的预测作用。一项 7 年随访研究。
J Alzheimers Dis. 2018;63(4):1523-1535. doi: 10.3233/JAD-171180.

引用本文的文献

1
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease.血液生物标志物证实,主观认知衰退(SCD)在阿尔茨海默病的美国国立衰老研究所-阿尔茨海默病协会(NIA-AA)框架内是一个独特的分子和临床阶段。
Mol Psychiatry. 2025 Apr 18. doi: 10.1038/s41380-025-03021-0.
2
Characterization of subclinical depressive and anxiety symptoms in older adults with subjective cognitive decline progressing to objective cognitive impairment: A prospective 4-year follow-up study.主观认知下降进展为客观认知障碍的老年人亚临床抑郁和焦虑症状的特征:一项前瞻性4年随访研究。
J Alzheimers Dis. 2025 Apr;104(3):720-731. doi: 10.1177/13872877251319538. Epub 2025 Mar 17.
3

本文引用的文献

1
A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.临床阿尔茨海默病性痴呆和轻度认知障碍发展中的认知转折点:一项双种族人群研究。
J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):424-430. doi: 10.1093/gerona/glw246.
2
Implementation of subjective cognitive decline criteria in research studies.研究中主观认知衰退标准的实施。
Alzheimers Dement. 2017 Mar;13(3):296-311. doi: 10.1016/j.jalz.2016.09.012. Epub 2016 Nov 5.
3
Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: Differential affective and imaging correlates.
Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study.
根据基线生物标志物分析主观认知衰退的认知与神经退行性轨迹:CoSCo研究结果
Alzheimers Dement. 2025 Feb;21(2):e14473. doi: 10.1002/alz.14473. Epub 2024 Dec 28.
4
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.基于人群的无痴呆队列中的多模态神经影像生物标志物与轻微认知衰退
J Alzheimers Dis. 2025 Jan;103(2):570-581. doi: 10.1177/13872877241303926. Epub 2024 Dec 19.
5
Subjective cognitive complaints and future risk of dementia and cognitive impairment, which matters most.主观认知主诉与痴呆症和认知障碍的未来风险,何者最为重要。
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2025 Jul;32(4):586-597. doi: 10.1080/13825585.2024.2443059. Epub 2024 Dec 18.
6
Identifying older adults at risk for dementia based on smartphone data obtained during a wayfinding task in the real world.基于在现实世界寻路任务中获取的智能手机数据识别有患痴呆症风险的老年人。
PLOS Digit Health. 2024 Oct 3;3(10):e0000613. doi: 10.1371/journal.pdig.0000613. eCollection 2024 Oct.
7
Self- and study partner-reported cognitive decline in older adults without dementia: The role of α-synuclein and amyloid biomarkers in the Alzheimer's Disease Neuroimaging Initiative.老年人中无痴呆症患者的自我和学习伙伴报告的认知能力下降:阿尔茨海默病神经影像学倡议中α-突触核蛋白和淀粉样蛋白生物标志物的作用。
Alzheimers Dement. 2024 Nov;20(11):7777-7787. doi: 10.1002/alz.14239. Epub 2024 Sep 23.
8
Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts.淀粉样蛋白和 SCD 共同预测中德队列认知能力下降。
Alzheimers Dement. 2024 Sep;20(9):5926-5939. doi: 10.1002/alz.14119. Epub 2024 Jul 27.
9
Confronting Alzheimer's Disease Risk in Women: A Feasibility Study of Memory Screening as Part of the Annual Gynecological Well-Woman Visit.应对女性患阿尔茨海默病的风险:一项关于将记忆筛查作为年度妇科健康检查一部分的可行性研究。
J Womens Health (Larchmt). 2024 Sep;33(9):1211-1218. doi: 10.1089/jwh.2023.0843. Epub 2024 Jul 5.
10
A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer's disease.一项针对因阿尔茨海默病导致轻度认知障碍的老年患者的改良阿特金斯饮食的随机可行性试验。
Front Endocrinol (Lausanne). 2024 Mar 4;15:1182519. doi: 10.3389/fendo.2024.1182519. eCollection 2024.
社区或记忆诊所认知正常老年人的主观认知下降:不同的情感和影像相关性。
Alzheimers Dement. 2017 May;13(5):550-560. doi: 10.1016/j.jalz.2016.08.011. Epub 2016 Sep 28.
4
Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.在一个多样化的基于诊所和社区的老年队列中,从正常认知发展到轻度认知障碍。
Alzheimers Dement. 2017 Apr;13(4):399-405. doi: 10.1016/j.jalz.2016.07.151. Epub 2016 Aug 30.
5
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.临床前阿尔茨海默病临床试验中主观认知衰退效用的概念化
J Mol Neurosci. 2016 Nov;60(3):354-361. doi: 10.1007/s12031-016-0810-z. Epub 2016 Aug 11.
6
Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis.从轻度认知障碍恢复至正常认知:一项荟萃分析。
Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):324-330. doi: 10.1097/WAD.0000000000000145.
7
Importance of home study visit capacity in dementia studies.家庭访视能力在痴呆症研究中的重要性。
Alzheimers Dement. 2016 Apr;12(4):419-26. doi: 10.1016/j.jalz.2015.10.007. Epub 2015 Nov 18.
8
Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline.主观认知衰退研究中抽样和招募方法的影响
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S99-S107. doi: 10.3233/JAD-150189.
9
APOE gene polymorphism and risk of coronary stenosis in Pakistani population.载脂蛋白E基因多态性与巴基斯坦人群冠状动脉狭窄风险
Biomed Res Int. 2015;2015:587465. doi: 10.1155/2015/587465. Epub 2015 Mar 26.
10
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.临床前阿尔茨海默病主观认知下降研究的概念框架。
Alzheimers Dement. 2014 Nov;10(6):844-52. doi: 10.1016/j.jalz.2014.01.001. Epub 2014 May 3.